Philip Hemme, Author at Labiotech.eu

About

Young French-German Entrepreneur, Co-founder & CEO of Labiotech.eu. High-level table tennis player, and German beer/French Wine lover 🙂

Articles by Philip Hemme

News and Trends 1 Nov 2014

Apply to OneStart to win €125k for your life sciences/health care business idea

OneStart, organized by Oxbridge Biotech Roundtable and SR One, GSK’s corporate venture capital arm, is today the world’s largest life science/healthcare startup accelerator. Apply by December 1st, 2014 for the chance to win £100k (€125k) as well as free lab space. Do you have an idea, an entrepreneurial opportunity or have you already started? Discover why you […]

November 1, 2014 - 2 minutesmins - By Philip Hemme

News and Trends 29 Oct 2014

Sanofi Fires its CEO Chris Viehbacher

Breaking news for French Pharma company Sanofi. The Board decided to fire Christopher Viehbacher, who was leading the company since December 2008. Chris Viehbacher, German-Canadian, was the first non-French CEO of Sanofi, second largest French company. He had a tough management and tried to transform Sanofi (maybe too much). He managed Sanofi’s transition to Biotech/Biologicals with […]

October 29, 2014 - 2 minutesmins - By Philip Hemme

News and Trends 25 Oct 2014

Belgian Promethera received approval to start World first Phase IIb/III stem-cell based urea cycle disorders treatment

Promethera is a promising Belgian Biotechnology company developing stem-cell based treatment against liver diseases. It was created in 2009, counts 44 employees and has raised €39M. The company now moves to another level by starting its own Phase IIb/III to treat paediatric patients with urea cycle disorders. It is the first company in the World […]

October 25, 2014 - 1 minutemin - By Philip Hemme

News and Trends 17 Oct 2014

Should European Biotech CEOs wear more sneakers?

Today is Friday or Casual Day. Did you leave the suit and the tie at home to wear jeans and sneakers? Should you have done so? More and more people do so on Friday but also the rest of the week. The American Tech industry and the Silicone Valley started the movement. Steve Jobs is probably the most […]

October 17, 2014 - 3 minutesmins - By Philip Hemme

News and Trends 10 Oct 2014

How Gilead’s Hepatitis C Treatment challenges European Public Health Systems

American Biotech company Gilead is selling its new drug Sovaldi since 2013, which brings significant breakthrough in Hepatitis C treatment. The high cost of the drug, up to €100 000, is a challenge for european Public Health system which tries to lower its overall cost for their public health system. Hepatitis C is an infectious disease […]

October 10, 2014 - 3 minutesmins - By Philip Hemme

News and Trends 3 Oct 2014

A new way to develop therapeutic monoclonal antibodies against Cancer

Up to now, a vast majority of antibodies targets proteins. Why not targeting something else? ImmuSmol, a start-up based in Bordeaux South of France is developing monoclonal antibodies against small molecules involved in tumor immune escape. This French start-up has just raised €500k to complete its preclinical proof-of-concept. Bordeaux is one of the biggest wine […]

October 3, 2014 - 2 minutesmins - By Philip Hemme

News and Trends 22 Sep 2014

Is a new revolution in lung cancer drug treatment coming ?

A new revolutionary treatment could help cure lung cancer. It is based on mRNA instead of antibodies and chemotherapy. Instead of delivering the protein or the drug, only a message is delivering and the body will produce the therapeutics. Curevac, the historic and one of the leading Biotech company in this field announced a 465 million […]

September 22, 2014 - 3 minutesmins - By Philip Hemme

Presentation www.labiotech.eu Betahaus 2 long

News and Trends 19 Sep 2014

Public launch of LaBiotech.eu at Betahaus Berlin

Hello everyone, Yesterday, we publicly launched LaBiotech.eu at Betahaus Berlin, the biggest co-working space of the city. It was the big day for the third project of LaBiotech Group after LaBiotech.fr, the leading French biotech news website, and LaBiotech Tour, the first World Tour of Biotech ecosystem. Europe had until now several well-established printed newspaper […]

September 19, 2014 - 1 minutemin - By Philip Hemme

News and Trends 18 Sep 2014

Would you be interested by MinION, the first pocket DNA sequencer ?

The first next-gen sequencing device of the size of an iPhone has been shipped. It is called MinION and is developed by the Oxford-based company Nanopore technologies. The long research and development process has finally paid off. How can a next-gen sequencer hold in a so small device? It uses a newly developed nanopore sequencing method. […]

September 18, 2014 - 3 minutesmins - By Philip Hemme

News and Trends 15 Jul 2014

Relive BIO 2014, the World’s Biggest Biotech Convention

Relive BIO 2014 exhibition was held from the June 23rd to June 26th in San Diego, California and I was lucky to go there. 15667 other people, including 2,500 CEOs from more than 50 different countries came too. Why this event fascinates? Why major biotech actors in the world are meeting there every year? I will try to answer these […]

July 15, 2014 - 5 minutesmins - By Philip Hemme

News and Trends 19 May 2014

Discover Hello Tomorrow Challenge, European largest technological start-up challenge

I was lucky to be invited as a media partner for the first edition of Hello Tomorrow Challenge (HTC) on April 18 at the Museum of Science and Industry in Paris. Technological innovations of the future were highlighted and rewarded by over 400k€. The event gathered over 1,200 attendees and focused on five major areas that […]

May 19, 2014 - 3 minutesmins - By Philip Hemme

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Philip Hemme

About

Articles by Philip Hemme

Apply to OneStart to win €125k for your life sciences/health care business idea

Sanofi Fires its CEO Chris Viehbacher

Belgian Promethera received approval to start World first Phase IIb/III stem-cell based urea cycle disorders treatment

Should European Biotech CEOs wear more sneakers?

How Gilead’s Hepatitis C Treatment challenges European Public Health Systems

A new way to develop therapeutic monoclonal antibodies against Cancer

Is a new revolution in lung cancer drug treatment coming ?

Public launch of LaBiotech.eu at Betahaus Berlin

Would you be interested by MinION, the first pocket DNA sequencer ?

Relive BIO 2014, the World’s Biggest Biotech Convention

Discover Hello Tomorrow Challenge, European largest technological start-up challenge

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by Philip Hemme

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!